Our company offers the widest variety of drug testing panels in the market. Please see a list of the standard panels we offer listed below. If you donâ€™t see what you are looking for, don't be discouraged, we will work with you to figure out the best option.
We understand that the hustle and bustle of 21st century lives don't always permit timely arrivals to appointments. With you in mind, we have created a system that moves just as quickly as you do.The running late, rescheduling and remorse for missing an appointment ends here and now.
Our new and improved ‘ticket system’ is now more convenient than ever.
Whether you call a few days in advance or while en route to your local clinic, our call center representatives are eager to assist you 24/7. Upon receiving your call, your representative will issue a personalized test ticket with a barcode number, for you to present with your photo ID at the clinic on arrival. No printer? No problem! Your barcode number can be emailed, faxed, or given to you over the phone.
Give us a call at
24/7. Our well seasoned call center representatives are eager to assist you, or place your order!
Q: What testing methodology does Detect Lab use to perform initial drug screening?
A: Detect Lab performs initial drug screening using immunoassay. An immunoassay is a test that uses antibodies to detect the presence of drugs and other substances in urine. The initial screening process does not measure the specific amount of drug present in urine samples. It provides either a positive or negative result, indicating the presence or absence of detectable drug.
Q: What is GC/MS?
A: GC/MS is the abbreviation for gas chromatography/mass spectrometry, the testing methodology Detect Lab uses to confirm presumptive positive drug screen specimens. GC/MS provides identification of the molecule(s) based on characteristic fragmentation patterns at specific retention times. GC/MS is a tandem technology, utilizing a gas chromatograph coupled to a mass spectrometer.
Q: Why are screening and confirmation cut-off levels different?
A: Simply stated, screening and confirmation testing are performed using different testing methodologies that precipitate different cut-off levels. The immunoassay tests used to perform initial drug screening are designed to detect a wide range of chemically similar compounds that react with the antibodies which are at the core of the chemistry making up the tests. In contrast, GC/MS confirmatory testing detects specific metabolites that provide identification and quantification of a specific drug.
Q: To what does ng/mL refer?
A: Drug testing cut-off levels are usually expressed in the units of measure ng/mL (nanograms per milliliter). A quantitative positive GC/MS result is expressed in ng/mL.
Q: What is methamphetamine "d" and "l" isomer testing?
A: Methamphetamine is available in two forms: "d" and "l." These compounds are stereoisomers (chemical mirror images). They have the same chemical formula and similar chemical properties. The "d" form is a prescription stimulant and appetite suppressant. The "l" form is available over-the-counter as the active ingredient of the Vick's inhaler and is a metabolite of certain prescription medications. Both "d" and "l" test positive by both immunoassay and most GC/MS assays.
Q: What do the percentages mean in methamphetamine "d" and "l" isomer test results?
A: In order to help determine whether a methamphetamine positive may be due to an illicit source, it is helpful to determine the percentage of "d" isomer. For example, following an individual's use of Vick's Vapor Inhaler, the expected result would be 100% "l" methamphetamine. However, there is a possibility that trace amounts of "d" isomer may be present in the quantitative analysis. Laboratory guidelines have been established to allow for trace presence of the "d" isomer. If the laboratory report indicates more than 80% "l" methamphetamine, the results are consistent with Vick's Vapor Inhaler use. If the laboratory reports more than 20% "d" methamphetamine present, the result indicates the use of "d" methamphetamine other than the inhaler. Illegally produced methamphetamine and amphetamine may contain mixtures of "d" and "l" isomers. Detect Lab always use a medical review officer (MRO) to review all non-negative test results.
Q: What is the drug MDMA/Ecstasy?
A: Ecstasy is a commonly used street-name for MDMA (3,4-methylenedioxymethamphetamine). MDMA is an illegal drug with characteristics of both stimulants and hallucinogens. In the mid 1980s, MDMA was being used at all night dance parties, now referred to as "raves". In 1985, the US Drug Enforcement Administration moved the drug to Schedule 1 status with no accepted medical use.
Q: Why isn't MDMA detected in my standard amphetamine screen?
A: MDMA is a synthetic amphetamine structure and does cross-react with existing amphetamine assays. However, the cut-offs established for amphetamine by the government do not pick up concentrations of MDMA in urine that are typically there following exposure. To enable detection of MDMA following normal exposures, Detect Lab uses reagents developed specifically for MDMA detection.
A: 6-acetylemorphine (6-AM) is an intermediate metabolite between heroin and morphine. Generally, 6-AM is present for a short time after use of heroin.
Q: What tests does Detect Lab offer to detect synthetic opiates?
A: Detect Lab offers an opiate 4 test that is designed to detect codeine, morphine, hydrocodone, and hydromorphone.
Additionally, Detect Lab offers a screening and confirmation test specifically designed to detect oxycodone
Q: What are OxyContin® and oxycodone?
A: OxyContin® tablets are a controlled-release oral formulation of oxycodone hydrochloride generally indicated for the management of moderate to severe pain when a continuous, around-the-clock analgesic is needed for an extended period. Oxycodone is a semisynthetic narcotic analgesic classified by the US Drug Enforcement Administration as a Schedule II controlled substance with an abuse liability similar to morphine.
A: Specimen validity testing (SVT) is performed on a drug screen specimen to detect substitution, adulteration, or dilution. See the Drugs of Abuse Reference Guide for additional information on SVT.
Substitution - Submission of a specimen that is not characteristic of human urine.
Typically, this may be water or water with salt in it and is identified by extreme creatinine and specific gravity results.
Adulteration - Adding a substance to a specimen after it has been collected. The product added is designed to mask the presence of, or chemically destroy, the drug or drug metabolite that the specimen may contain. An adulterant product may be added with the intention of adversely affecting the testing reagents.
Dilution - Result of ingestion of large amounts of water typically just before urine donation or as a result of physiological conditions. Specimens meeting dilute specifications typically are not considered questionable donations.
Q: Does the lab conduct SVT before screening for drugs?
A: No, specimen validity testing is performed simultaneously with the initial drug screens. Depending upon the drug screen and the specimen validity results, the laboratory will release (1) both the drug screen and the specimen validity test results, (2) the specimen validity test results only, or (3) the drug screen results only.
Q: Is the nitrite test threshold based on body functions, or does it allow for infection, food ingestion with high nitrates, and water consumption with high nitrites?
A: The nitrite threshold level established by the Federal Government is 500ug/mL. This is based on the level at which a drug screen may be impacted by this adulterant and by which no normal physiological level has been detected.
Q: How would a drug test be evaluated when nitrates are 490 ng/mL?
A: The nitrite result would be negative, as this level would not interfere with our testing process. The drug test(s) ordered would be conducted and reported following standard operating procedures.
A Medical Review Officer (MRO) is a person who is a licensed physician and who is responsible for receiving and reviewing laboratory results generated by a drug testing program and evaluating medical explanations for certain drug test results.
MRO acts as an independent and impartial "gatekeeper" and advocate for the accuracy and integrity of the drug testing process. MRO's provides quality assurance review of the drug testing process for the specimens under your purview, determine if there is a legitimate medical explanation for laboratory confirmed positive, adulterated, substituted and invalid drug test results, ensure the timely flow of test result and other information to employers and protect the confidentiality of the drug testing information.
The MRO reviews the lab results to makes sure the correct test panel was performed and that the correct procedures were followed by the collector. When a drug test is reported positive by the lab, the MRO also contacts the donor to determine if there is a legitimate medical explanation for the positive lab result. Some prescription medications or medical treatments can cause a positive test result. In these cases, the MRO will obtain verification of a valid prescription or recent medical treatment. The test result is then reported as negative because there is a legitimate, verified medical reason for the positive lab test result. However, if the donor is unable to provide a valid medical explanation for a positive lab test result, the MRO reports the test result as positive.
Using an MRO to review and interpret the laboratory test results protects the employer, court, and the donor from having to make decisions regarding a claims that his or her drug test result was caused by a medication or medical treatment. It also keeps the all parties from having to deal with the complicated issues related to the release or disclosure of private donor's medical information.
MRO review is required for every Department of Transportation (DOT) drug test. It is highly recommended that employers utilize the services of an MRO for all drug testing, even if it is not required by state law.
The following chart from Detect Lab gives approximate detection periods for each substance by test type.
The detection windows depend upon multiple factors - drug class, amount and frequency of use, metabolic rate, body mass, age, overall health, and urine pH. For ease of use, the detection times of metabolites have been incorporated into each parent drug. For example, heroin and cocaine can only be detected for a few hours after use, but their metabolites can be detected for several days in urine. In this type of situation, we will report the (longer) detection times of the metabolites.